The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Rayne H. Rouce(Baylor College of Medicine)
Cited by 267
Related Papers
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
|Blood|2020|284
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
|Journal of Clinical Investigation|2021|245
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|236